Contents
Generation Bio is a company founded by Andrew Scharenberg, Mark D. Angelino, and Robert Kotin. The company has its headquarters located in Massachusetts, United States, and develops gene therapy treatments for patients suffering from rare and prevalent diseases.
Timeline
February 2018
Generation Bio raises a $100,000,000 series B round from Casdin Capital, Deerfield Management Company, Foresite Capital, Invus and Leerink Partners.
January 4, 2018
Generation Bio raises a $25,000,000 series A round from Atlas Venture.
2016
Generation Bio was founded by Andy Scharenberg and Mark Angelino.
Funding Rounds
Open in Query Tool
Products
Open in Query Tool
Acquisitions
Open in Query Tool
SBIR/STTR Awards
Open in Query Tool
Patents
Open in Query Tool
Further Resources
Title
Author
Link
Type
Date
References
Company attributes
Industry
Location
B2X
Pitchbook URL
Legal Name
Generation Bio Co.
Legal classification
Date Incorporated
2016
Number of Employees (Ranges)
100 – 249
Full Address
301 Binney Street Cambridge, MA 02142
CIK Number
Place of Incorporation
Investors
IRS Number
814,301,281
Email Address
info@generationbio.com
investors@generationbio.com
media@generationbio.com
partnering@generationbio.com
Phone Number
+16176557500
Total Funding Amount (USD)
336,842,608
Latest Funding Round Date
January 2020
Competitors
Stock Symbol
GBIO
Exchange
Glassdoor ID
Board of Directors
Latest Funding Type
Other attributes
Company Operating Status
Active
Country
Ticker Symbol
GBIO
SIC Code
2,834
